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CONTROL OF END-TIDAL HALOTHANE CONCENTRATION
Part A : Anaesthesia Breathing System and Feedback Control of Gas Delivery
D. R. WESTENSKOW, A. M. ZBINDEN, D. A. THOMSON
AND B. KOHLER
Feedback has been used in anaesthesia to control
the concentrations of inhalation anaesthetics, the
concentration of oxygen, the volume of ventilation
and the volume of the breathing system (Chilcoat,
1973; Coles, Brown and Lampard, 1973; Suppan,
1977; Mapleson et al., 1980; Tatnall, Morris and
West, 1981; Morris, Tatnall and Montgomery,
1983; Ross et al., 1983; Schils, Sasse and
Rideout, 1983; Westenskow, Jordan and Hayes,
1983a, b). Indeed, when the end-tidal concentra-
tions of the anaesthetic are controlled, induction
is shortened, and arterial and brain concentrations
achieve greater stability (Chilcoat, 1973; Morris,
Tatnall and Montgomery, 1983; Ross et al., 1983;
Schils, Sasse and Rideout, 1983; Westenskow,
Jordan and Hayes, 1983a, b). Moreover, if the
oxygen concentration and the volume of the
system are controlled, oxygen consumption (t^ Oj)
and halothane uptake (Fhal) can be measured
(Coles, Brown and Lampard, 1973; Barton and
Nunn, 1975; Bushman et al., 1977; Beatty et al.,
1982; Ross et al., 1983; Westenskow, Jordan and
Hayes, 1983a, b). With feedback control the
anaesthetic breathing system becomes easier to
use, and the pharmacokinetics of inhalation
anaesthesia can be studied, and taught, in detail.
However, conventional anaesthetic breathing
systems are not designed to control or measure the
uptake of oxygen or halothane: fittings are not
leak-tight, fresh gas fiowmeters are not precise
enough to measure low flows, the volume of the
system is difficult to measure and considerable
SUMMARY
Conventional anaesthetic breathing systems are
not designed to control end-tidal gas concentra-
tions, nor can they be used to measure accurately
the uptake of oxygen or of anaesthetic agent. We
built and tested a leak-tight closed-loop anaes-
thetic breathing system with low solubility to
volatile anaesthetic agents and with efficient gas
mixing. The system included a water-sealed
spirometer, a small carbon dioxide absorber, a
coaxial tube to the patient, a circulating pump
and feedback controllers for system volume and
anaesthetic concentration. Feedback control was
implemented to adjust and control automatically
the end-tidal anaesthetic concentration and the
volume of the system with oxygen supplied
through a mass flow controller and with
halothane supplied by a titrating syringe. Con-
troller gains, as a function of body weight, were
found using a nine-compartment tissue uptake
model. Stability was maintained with ±50%
changes in alveolar ventilation and cardiac
output. During subsequent investigations in an
animal model, arterial, mixed venous and cerebral
venous blood halothane concentrations were
measured to show that the feedback-controlled
halothane induction was optimized. We conclude
that feedback control appears to be clinically
applicable for adjusting the end-tidal halothane
concentration and system volume to provide a
rapid and optimized induction of anaesthesia.
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amounts of anaesthetic are absorbed by both
rubber and plastic as well as by soda-lime (Lowe,
Titel and Hagler, 1971; Morris, 1974; Grodin and
Epstein, 1979; Lowe and Ernst, 1981). Thus a new
design of breathing system and new sensors are
required before a closed-loop technique can be
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FIG. 1. Block diagram of closed-loop anaesthesia breathing system with feedback control. The infra-red
(IR) volume sensor in the spirometer is used to control the oxygen delivery to keep the system volume
constant. The infra-red (IR) anaesthetic sensor controls the halothane delivery to keep the end-tidal
concentration constant. The patient breathes from the outlet of a coaxial tube within a tube.
used to measure P^o,, and control the delivery of
the anaesthetic.
A leak-tight, closed-loop breathing system has
been constructed which ensures low solubility to
anaesthetics and efficient gas mixing. Feedback
control of the system was tuned using computer
simulation.Duringsubsequentanimal experiments
(see following paper (Zbinden et al., 1986)),
arterial, mixed venous and cerebral venous
blood-halothane concentrations were measured
and showed that feedback control optimized the
induction of anaesthesia.
MATERIALS AND METHODS
Figure 1 shows a rebreathing system incorporating
a water-sealed spirometer, a carbon dioxide
absorber, a coaxial tube, a circulator pump and
feedback controllers.
Breathing system
A water-sealed plexi-glass spirometer replaced
the traditional thin-walled rubber bellows. A
23-cm column of water between the spirometer
and a 2.0-litre polycarbonate bell provided a
gas-tight seal. An infra-red sensor (Opto modul
ONS 250, Grieshaber AG, Switzerland) mounted
in the top of the spirometer measured the position
of the bell and a Siemens 900 B Servo Ventilator
drove the bell to control ventilation. The carbon
dioxide absorber, containing 680 ml of soda-lime,
was a 60-cm plexi-glass tube of 3.8 cm i.d.—this
small diameter providing an effective seal to the
breathing tubes. The expiratory breathing tube
(4.5 mm i.d.) lay as a coaxial tube within the
inspiratory tube (18 mm i.d.). (Choosing the inner
coaxial tube as the expiratory limb did not increase
expiratory resistance as the patient could also
exhale into the outer tube.) However, this
arrangement prevented the pooling of condensed
water because it was immediately suctioned off
through the expiratory tube and transferred to the
carbon dioxide absorber and the bellows.
The circulating pump shown in figure 1 moved
gas through the rebreathing system at the rate of
25 litre min"1. The pump (Nalgene Company,
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Rochester, N.Y.) replaced functionally the
one-way valves of a rebreathing system and
insured that, during the expiratory pause, alveolar
gas was cleared from the expiratory breathing limb
and fresh gas was inspired with the next breath.
If the patient exhaled at a rate greater than
25 litre min"1, he exhaled into the inspiratory
limb, which was cleared during the subsequent
expiratory pause. The pump improved feedback
control by decreasing the delay time between the
injection of halothane to the system and its
detection by the gas analyser.
To ensure that the 2.5-litre system was
leak-tight, it was built of thick-walled, 18-mm i.d.
p.v.c. tubing. The system was sealed at the patient
connection by a rubber stopper and an oxygen flow
of 5 ml min"1 maintained the system pressure at
60 mm Hg. This small oxygen leak could be
ignored when using normal pressures of
20 mm Hg and a 1:1 inspired: expired ratio.
There was an additional apparent leak of halothane
from the uptake of halothane by the system. To
measure this uptake, the system was primed and
maintained at 0.87 vol % (1 MAC) for 1 h with the
system sealed at the patient connection with a
stopper, with normal ventilation and with carbon
dioxide added at 100 ml min"1. AO.lO-mlbolusof
liquid halothane filled the system to 0.87 vol % and
0.38 ml maintained the concentration for 1 h.
Inspired and end-tidal halothane concentrations
were measured with an infra-red sensor (LB-2,
Beckman Instruments, Inc., Fullerton, CA). A
500-ml min"1 sample taken at the mouthpiece was
returned to the breathing system after passing
through the heated infra-red sensor head. The
analyser was zeroed with room air and calibrated
with gas standards (AGA, Pratteln, Switzerland)
of 1.00±0.01 and 1.99±0.02 vol% halothane in
oxygen.
Oxygen was supplied to the system through a
mass flow controller (FC-260, Tylan, Torrence,
CA), accurate to ±0.5 % of full scale over a range
of 20-1000 ml min"1. The flow controller was
calibrated by a timed collection under a rising soap
bubble in a 100- or 1000-ml glass cylinder.
Liquid halothane was added to the system in
0.03-ul increments by a titrating syringe (Met-
rohm). Its effluent was collected over time and
weighed for calibration.
Feedback control
Classical proportional-integral (PI) control
action (fig. 2) adjusted the oxygen mass flow
controller and halothane titrating syringe. The
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FIG. 2. Analogue control circuit. In our application, the differential gain was set to zero. The integral
and proportional 20-K potentiometers were set to give the desired gains.
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input to the oxygen controller was the difference
between the averaged signal from the IR volume
sensor and a preset value corresponding with the
midpoint of the spirometer. The output of the
controller drove the oxygen flow controller. This
control action kept the spirometer bell in its
midposition by the addition of oxygen.
The oxygen controller was tuned by trial and
error while changing the system volume by 1-litre
steps. With a proportional gain of 2.5 min~l and
integral gain of 0.15 min~s, the bell reached its
midposition in 1.2 min. The proportional gain
(min"1) equalled the oxygen flow (ml min"1) into
the system divided by the difference between the
averaged system volume and a preset volume (ml).
The integral gain (min"1) equalled the oxygen flow
(ml min"1) into the system divided by the integral
over the time of the difference between the
averaged system volume and preset volume
(Jmldr = ml min). Integral gain units were,
therefore, ml min"1 ml"1 min"1 or min"1. The
oxygen flow controller's maximum of 1 litre min"1
was the main factor which limited the response
time.
The halothane controller also used the PI circuit
in figure 2. Its input was the difference between
the target end-tidal halothane concentration
and the measured end-tidal concentration taken
from the Beckman LB-2 peak detector. A voltage-
controlled oscillator converted the PI controller
output to discrete pulses to drive the titrating
syringe which then delivered 0.03 ml at each pulse.
This control action maintained the end-tidal
halothane concentration at the target value. For
the animal study, the gains were initially set at
proportional = 0.4 ml min"1 vol% -1 and inte-
gral = zero. When the animal study was completed,
the uptake model variables were modified to fit the
data and the model used to improve the tuning of
the halothane PI controller. Integral gain was
added to eliminate the offset error which appeared
in the animal study.
Tuning of the halothane controller
We used the uptake model of Zwart, Smith and
Beneken (1972), described in the appendix, to tune
the halothane controller. Our anaesthesia breathing
system (fig. 3) was modelled with two compart-
ments: a 2.5-litre physical volume and a 6.02-litre
virtual volume which simulated uptake by the
components of the system, including the soda-lime.
Gas transfer between the two compartments was
augmented by the circulating pump. This simple
model gave a match between simulated and
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FIG. 3. Block diagram of Zwart's anaesthetic uptake and circulation model. The model has halothane-
dependent blood flow to nine tissue compartments, halothane dependent (Jt, and fixed arterial-venous
shunt. We added the component for our breathing system and an end-tidal halothane calculation.
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FIG. 4. Measured and simulated halothane concentration following the delivery of 0.48 ml of liquid
halothane to the system. Halothane was given by titrating syringe. Concentration was measured by the
anaesthetic sensor at the patient connection. This curve was produced with soda-lime in the absorber,
a pump rate of 25 litre min"1 and carbon dioxide 100 ml min"1 added to simulate the animal's carbon
dioxide production.
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FIG. 5. Simulated response of the optimally tuned PI controller
showing inspired, end-tidal, arterial and brain grey tissue
concentrations. The model used a 20% arterial-venous shunt
and 30% alveolar deadspace.
measured concentrations after delivering a bolus
of halothane (0.48 ml) to the system (fig. 4). The
match was adequate for the purpose of tuning the
feedback controller.
The model was implemented in Fortran 77 on
a DEC 11/44 computer using a discrete time
model with a 1 -s time increment. Transport delays
were introduced as appropriate: 2 s for the
infusion of halothane, 3 s for the system inspiratory
limb and a further 3 s for the expiratory limb.
We used the model to tune the end-tidal
halothane PI controller (fig. 2). During closed-loop
simulation of induction, the proportional gain was
increased to increase the rate of increase in the
end-tidal concentration, but the inspired halothane
concentration was kept to a maximum of 3.0 vol %.
At this limit, end-tidal overshoot did not occur.
The integral gain was gradually increased until the
difference between the target and measured
end-tidal concentration was zero, which occurred
20 min after induction. However, as the integral
gain was increased, the proportional gain was
decreased to prevent the maximum concentration
from exceeding 3.0 vol%. For body weights (wt)
from 5 to 100 kg, the desired response was
achieved using the gains:
P = [0.015 (wt) + 0.29] ml min"1 vol0/,,-1
I = 0.006e°-057<wt) ml min"2 vol0/,"1
As the weight changed, the tidal volumes, blood
volumes, & (cardiac output), P^ A (alveolar
ventilation) and FRC (functional residual capacity)
were scaled linearly according to weight. The
simulated response for a 35-kg patient is shown in
figure 5.
Stability of end-tidal control was maintained
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FIG. 6. Simulated response with PA = 1.5 litre min"1,
3.0 litre min-' and 4.5 litre min"1. The upper three curves are
the inspired concentration, the bottom three are the
end-tidal.
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FIG. 7. Simulated response with initial (^ t of 4.1 litre min"1,
3.1 litre min"1 and 1.5 litre min"1.
despite significant changes in Vk and Qt. Using
the PI gains for a 35-kg patient, VA was increased
and decreased by 50 % with the results shown in
figure 6. Changing £)t by ±50% (fig. 7) had little
influence on end-tidal concentration.
DISCUSSION
The response time of our end-tidal halothane
controller was less than the 10-15 min reported for
other controllers using the closed-loop system
(Ross et al., 1983; Westenskow, Jordan and Hayes,
1983a, b), but more than the 1-2 min reported for
non-rebreathing system controllers (Mapleson
et al., 1980; Tatnall, Morris and West, 1981;
Morris, Tatnall and Montgomery, 1983). More
rapid responses could be achieved using our
controller in a non-rebreathing system where gas
concentrations, can be changed on a breath-to-
breath basis, but the advantages of the closed-loop
system (humidification, economy, ecology and
monitoring ^o s and Fhal) seemed more important
than a decrease in response time. Our closed-loop
controller achieved a more rapid response than
other closed-loop controllers as a result of rapid
mixing, small system volume and a well-tuned
controller.
A leak-tight breathing system should be ideal
for monitoring Vot if errors from nitrogen
accumulation, changes in FRC, and leaks are
avoided (Nunn and Pouliot, 1962; Owen-Thomas
et al., 1971; Nisbet et al., 1973; Barton and Nunn,
1975). Our breathing system was constructed to
overcome the leaks found in most commercial
systems, the water-sealed spirometer which re-
placed the: normal rubber bellows in the ventila-
tor being the most significant improvement. Our
feedback controller and precision mass flow
controllers kept volume constant and recorded the
inflow of fresh oxygen with a 1 % accuracy,
thereby obtaining an accurate measurement of
Vot.
The average system volume was kept constant,
but if the system is used during spontaneous
breathing it may be better to keep the end-
expiration system volume constant. With spon-
taneous breathing, the tidal volume will change
from breath to breath, causing the average system
volume to fluctuate. A device which measured the
system volume at end-expiration would be more
stable, as FRC is more constant than average lung
volume.
The accuracy of the Fhal measurement is not
known. The flow of halothane to the closed-loop
equals VhaA of the patient only after correction is
made for Fhal of the system. Our system used
metal and p.v.c. components and a small soda-lime
absorber to reduce system uptake, but approxi-
mately 0.48 ml of liquid halothane was taken up
by the system during the first 1 h at 1 MAC.
System uptake cannot be compensated for easily,
as it will change when the patient's Fco2 alters the
temperature and humidity of the soda-lime (Lowe,
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Titel and Hagler, 1971) and, therefore, its uptake
of halothane. As soda-lime accounts for more than
one-half of the total uptake by the system, and its
uptake depends on its state of hydration, l^ hal can
be measured accurately only after this variability
is accounted for.
Before the system can be used clinically, two
improvements are needed. The present circulation
pump could generate dangerous airway pressures
if the breathing hose became kinked, and carbon
dioxide rebreathing could occur if the pump
stopped. The circulating pump should be replaced
with a fail-safe, pressure-limited pump. Air
entrainment could result from a system leak and
feedback control systems may fail. Therefore,
secondary monitoring is required for oxygen
concentration, system volume and halothane
concentration. Feedback control does, however,
seem clinically applicable, the adjustments of
end-tidal halothane concentration providing a
rapid and optimal induction of anaesthesia.
APPENDIX
The uptake model of Zwart, Smith and Beneken (1972)
contains nine tissue compartments (fig. 3). The partial pressure
in each compartment is described by:
P(t) = P(o) + ,
where X = solubility coefficient for blood (b) and tissue (t)
P = agent partial pressure in tissue compartment (t), or
in blood entering the compartment (i) or in blood
leaving the compartment (o)
qb(t) = blood flow as a function of vascular conductance
and arterial halothane concentration, and
V = compartment tissue volume (t) or blood volume (b).
The agent partial pressure in the lungs is given by:
P(t) = P(o) + , 1
where V% <= functional residual capacity+ 0.5 tidal volume
Prt = agent partial pressure in venous blood
P,, = agent partial pressure in inspired air, and
jy(t) = ventilation of the lung corrected for deadspace.
The arterial and mixed venous compartments are:
P(t) = P(o) +
*-b 'b + ' t Kt
where Q •= cardiac output, and
Efl(t)Pj(t) = summation over all flows entering the com-
partment.
Halothane concentration in the physical compartment of the
anaesthesia breathing system is:
= Pc(o) + -
a
where u(t) = halothane added (litre min ' pure vapour as
ideal gas),
Pc(o) = halothane partial pressure initially in the system
a = 2.5-litre physical system volume (fig. 3)
c = 25-litre min"1 circulating pump speed (fig. 1),
and
PB = barometric pressure.
The concentration in the virtual compartment of breathing
system is:
P,(t) = dt
where PA = alveolar halothane partial pressure, and
b = 6.02-litre virtual system volume (figure 3—
uptake by the breathing system and soda-lime).
To the model we added a calculation for the end-tidal
halothane partial pressure (PTial). The end-tidal gas is a
mixture of alveolar gas and alveolar deadspace (KD) gas.
Theoretically the deadspace gas has the tame halothane
concentration as the inspired gas (P,) because it comes from
nonperfused regions which empty in parallel with alveolar
compartments. The relative contribution of fj and PA to the
end-tidal gas is assumed to be directly proportional to the
alveolar deadspace fraction (VD/VA):
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